This site uses cookies to store information on your computer. Learn more x

DSM delivers continued strong earnings and cash performance in Q3

Heerlen, NL, 02 Nov 2010 07:15 CET

  • Q3 operating profit from continuing operations up 28% to € 185 million (versus € 144 million in Q3 2009)
  • Sales growth from continuing operations 19% compared to Q3 2009
  • Continued strong Nutrition performance drives Life Sciences results
  • Very good results for Materials Sciences
  • Cash flow from operating activities in Q3 € 330 million
  • New strategy announced; DSM in motion: driving focused growth
  • Dividend increase of € 0.10 to € 1.30 per ordinary share proposed for 2010
  • Based on the continued positive business environment, 2010 is expected to be a strong year for DSM

Commenting on the results, Feike Sijbesma, Chairman of the DSM Managing Board, said: “I am pleased to report another strong quarter. Operating profit increased by almost 30% compared to the same period last year. Nutrition delivered a continued excellent performance, whilst Materials Sciences also posted very good results. Our strong market focus, disciplined cost and cash management and a broadly improving business environment helped drive these results. Based on the continued positive business environment we expect 2010 to be a strong year for DSM.

The announcement of our new corporate strategy – DSM in motion: driving focused growth – marks the shift from a period of intensive portfolio management to an era of maximizing sustainable, profitable growth of the ‘new’ DSM. We are committed to fully leverage the unique opportunities in Life Sciences and Materials Sciences. With our focus on high growth economies, innovation and sustainability and with our strong capital structure and leadership in biotechnology we are in an excellent position to deliver on our ambitious sales and profit targets.”

Related links